Yuhan Outlines Clinical Progress for Oral Targeted Anticancer Candidate YH42946 at WCLC 2026
Yuhan Corporation has detailed the status and trial design of the ongoing Phase 1/2 clinical study for YH42946, an oral targeted anticancer candidate...
Search results for "targeted anticancer drug"
Can Daraxonrasib Reshape Pancreatic Cancer Care? Experts Weigh Promise and Limits
Pancreatic cancer remains one of the most formidable malignancies. Because early-stage disease rarely produces distinct symptoms, many cases have...
Turning Off Cancer Signals: New Precision Drug Stops Tumors Without Harming Healthy Cells
South Korean researchers have developed a novel anticancer approach capable of selectively turning off specific...
AI Cancer Gene Analysis and 810 Billion-Won Tech Export Lead South Korea's Top 30 Health Care R&D Achievements
The Ministry of Health and Welfare and the Korea Health Industry Development Institute announced on the 8th that they...
Novartis to Buy UK Biotech Myricx for Up to $1.5 Billion, Boosting ADC Portfolio
Novartis is significantly expanding its oncology portfolio after securing an antibody-drug conjugate technology...
Radioembolization Extends Survival in Select Patients with Advanced Liver Cancer, Study Finds
Hearing a doctor say that “the cancer has invaded the portal vein” can be deeply overwhelming for patients with liver...
Nasal Drug Delivery Shows Promise for Deadly Glioblastoma Brain Tumors
A new type of cancer treatment delivered through the nose, rather than by conventional injection, is gaining...
Will a 'Second Gleevec' Emerge? The Race Heats Up for Rare Gastrointestinal Cancer Breakthroughs
A rare cancer can form in the wall of the stomach or intestines: gastrointestinal stromal tumor, or GIST.
Idience Targeted Cancer Drug Candidate ‘Venadaparib’ Granted FDA Fast Track Designation
Idience, a novel anticancer drug developer under the Ildong Pharmaceutical Group, announced on the 18th that its...
Datroway Approved: New Targeted Therapy Offers Hope for Metastatic Breast Cancer
A new therapeutic horizon has arrived for patients battling metastatic breast cancer that has progressed despite...